Here We Go Again — Another Failure of Postmarketing Device Surveillance

U.S. patients continue to be exposed to underperforming and potentially hazardous medical devices after FDA approval. Most recently, Riata and Riata ST implantable cardioverter–defibrillator leads — currently implanted in more than 75,000 U.S. patients — were recalled. The goal of postmarketing surv...

Ausführliche Beschreibung

Bibliographische Detailangaben

Veröffentlicht in:	The New England journal of medicine 2012-03, Vol.366 (10), p.873-875
1. Verfasser:	Hauser, Robert G
Format:	Artikel
Sprache:	eng
Schlagworte:	Death, Sudden, Cardiac - etiology Defibrillators Defibrillators, Implantable - adverse effects Earnings Humans Medical equipment Patient Safety Physicians Product Surveillance, Postmarketing - methods Prosthesis Design Prosthesis Failure United States
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!